Unknown

Dataset Information

0

Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma.


ABSTRACT:

Purpose

We retrospectively evaluated the prognostic significance of lymph node ratio (LNR) in patients with esophageal squamous cell carcinoma who underwent neoadjuvant concurrent chemoradiation therapy (NCRT) followed by surgery.

Materials and methods

In total, 270 patients who underwent NCRT followed by surgery between August 2005 and December 2015 were included. They were divided into three groups: LNR 0 (n = 196), LNR low (0 < LNR ? 0.1; n = 63), and LNR high (>0.1; n = 11). The primary endpoint was overall survival (OS), and the secondary endpoints were freedom from local recurrence (FFLR), distant metastasis-free survival (DMFS), and disease-free survival (DFS).

Results

The median number of retrieved lymph nodes per patient was 33. Pathologically, 74 patients had positive lymph nodes. The median follow-up duration was 36.1 months, and the median survival period was 68.4 months. There was a significant correlation between LNR and the number of positive lymph nodes (correlation coefficient = 0.763, p < 0.001). There was a substantial difference in the OS among the LNR groups, with 2-year survival rates of 79.0%, 54.0%, and 9.1% in the LNR 0, LNR low, and LNR high groups, respectively (p < 0.001). A marked decrease in FFLP, DMFS, and DFS was observed with the increasing LNR. In subgroup analysis, the survival results of patients with clinically positive lymph node were similar from those of entire cohort.

Conclusion

LNR is a significant prognostic factor in patients with esophageal squamous cell carcinoma who underwent NCRT followed by surgery. Additional treatment and closer follow-up would be necessary for patients with a high LNR.

SUBMITTER: Jang JY 

PROVIDER: S-EPMC7785840 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma.

Jang Jeong Yun JY   Yu Jesang J   Song Kye Jin KJ   Jo Yoon Young YY   Yoo Ye Jin YJ   Kim Sung-Bae SB   Park Sook Ryun SR   Kim Young-Hee YH   Kim Hyeong Ryul HR   Kim Jong Hoon JH  

Radiation oncology journal 20201125 4


<h4>Purpose</h4>We retrospectively evaluated the prognostic significance of lymph node ratio (LNR) in patients with esophageal squamous cell carcinoma who underwent neoadjuvant concurrent chemoradiation therapy (NCRT) followed by surgery.<h4>Materials and methods</h4>In total, 270 patients who underwent NCRT followed by surgery between August 2005 and December 2015 were included. They were divided into three groups: LNR 0 (n = 196), LNR low (0 < LNR ≤ 0.1; n = 63), and LNR high (>0.1; n = 11). T  ...[more]

Similar Datasets

| S-EPMC8955080 | biostudies-literature
| S-EPMC8164460 | biostudies-literature
| S-EPMC5150247 | biostudies-literature
| S-EPMC9554450 | biostudies-literature
| S-EPMC10977715 | biostudies-literature
| S-EPMC6353728 | biostudies-literature
| S-EPMC8017315 | biostudies-literature
| S-EPMC8894409 | biostudies-literature
| S-EPMC7139068 | biostudies-literature
| S-EPMC8247378 | biostudies-literature